Testing Patient Education Materials in Medical Technology: Minds

Clinical marketing managers at medical device manufacturers face the challenge of translating highly complex medical processes into accessible patient education materials. Minds enables iterative testing of brochures, explanatory graphics, and digital instructions across synthetic patient target groups spanning different age cohorts and educational backgrounds. This delivers qualitative directional signals on copy clarity and perception without passing through length ethics approval processes or exposing patients to risks in live test runs. For final regulatory submissions, clinical validations remain necessary.

The job to be done

When launching and supporting Class IIa, IIb, or III medical devices, such as continuous glucose monitoring systems, home respiratory therapy devices, or insulin pumps, clear patient education is critical. Clinical marketing managers must ensure that patients across diverse age groups, from young adults to seniors with cognitive impairments, correctly grasp operation procedures, safety warnings, and therapy steps. A single ambiguous section in a brochure or app guide can lead to operating errors, increased support hotline queries, or, in the worst-case scenario, adverse events. At the same time, internal review cycles with legal, regulatory affairs, and medical affairs are exceptionally long. The core problem is the disconnect between the technical medical language used by engineers and the everyday language of patients. The job to be done is to rapidly evaluate drafts of educational materials for clarity, tone, and accessibility, enabling teams to enter final sign-off cycles with well-founded optimizations.

What today's workflow looks like (and where it breaks)

Historically, clinical marketing managers have relied on traditional market research agencies, focus groups with real patients, or internal review rounds. However, conventional patient research is exceptionally resource-intensive. Recruiting patients with specific conditions often takes many weeks. Furthermore, studies involving real patients frequently require alignment with ethics committees or data protection officers because health data is highly sensitive. In many cases, teams forgo comprehensive pre-testing due to time and budget constraints, relying instead on the internal judgment of colleagues. This approach creates an insular tunnel vision, as engineers and medical managers take specialized terminology for granted. Traditional focus groups are also costly and provide limited sample sizes. By the time feedback arrives weeks later, layout and copywriting processes are typically so far along that major revisions cause massive delays.

The Minds workflow

• Step 1: Patient segment definition and template import The clinical marketing manager uploads drafts of the educational materials as text, PDF, or image files into the workspace environment. In addition, relevant target audience parameters are defined, such as age cohorts from 18 to 85 years, education level, digital literacy, and severity of pre-existing conditions.
• Step 2: Generation of synthetic patient groups Based on the entered descriptions and optional background documents, specific AI personas are generated. These represent different patient types, such as older chronically ill individuals with impaired vision or younger newly diagnosed patients with high digital literacy.
• Step 3: Test scenario setup The research question is structured within Minds. The manager defines specific questions regarding copy comprehension, technical terms, visual navigation, and the perception of warning notices.
• Step 4: Execution of the simulated survey Minds conducts the survey across the synthetic target groups. The system analyzes how different personas interpret individual paragraphs, where ambiguities arise, and which phrasing triggers confusion or misunderstanding.
• Step 5: Evaluation of the comprehension analysis The manager receives a structured qualitative evaluation. This highlights exactly which technical terms were misunderstood by older patient groups and which passages caused confusion.
• Step 6: Iterative copy and design adjustments Based on these insights, the marketing team refines text and visuals directly. Phrasing is simplified, bullet points are added, and warning notices are highlighted more prominently.
• Step 7: Re-testing the optimized draft The revised draft is tested again against synthetic target groups in a second run to confirm whether clarity has improved across all age brackets.
• Step 8: Handover to Medical Affairs and Legal Armed with simulated feedback data, the clinical marketing manager can confidently hand off the optimized draft to medical and legal teams, knowing potential comprehension barriers have already been resolved.

Sample output

A typical output in Minds for a new insulin pump education brochure provides precise qualitative feedback broken down by age segment. For example, the system identifies that the synthetic persona representing seniors aged 70+ misunderstands the term bolus calculator and perceives the step-by-step needle replacement graphic as overly complex. Conversely, feedback from the young adult segment (ages 18 to 30) indicates that the tone feels overly patronizing. The output delivers contextual quotes alongside concrete phrasing suggestions for simplification. For quantitative preference testing within the Studies module, structured analytical methods such as segment comparisons or top/bottom box scoring are available to directly evaluate the relative clarity of different copy variants. Each finding is traceable back to the specific paragraph that produced it, so writers can act on a single sentence rather than rewriting an entire section. Directional signals of this kind narrow the field before human validation; they do not replace it.

Why this beats the alternative

The decisive advantage of Minds in this use case lies in simulating patient understanding without the administrative and ethical hurdles of conventional studies. With traditional patient research, approval processes and participant recruitment delay go-to-market by months. Furthermore, conducting surveys with real patients on sensitive medical conditions always carries a risk of creating uncertainty or misinterpretation during testing. Minds empowers clinical marketing managers to test any number of copy variants in hours rather than months without involving ethics committees or placing burdens on patients. Costs remain a fraction of a traditional panel study because there are no recruitment fees per participant. It delivers fast, directional insights during the iterative development process, allowing expensive physical panels to be reserved strictly for final confirmation at the very end.

Next step

Clinical marketing managers looking to systematically optimize the clarity of their patient materials without risk can explore the exact methodological process in greater depth. Learn how to configure synthetic patient groups for your medical device products and integrate them into your existing sign-off workflow. Get started directly with an analysis of your requirements via our methodology deep dive registration at Minds.